Liquidia Corporation (NASDAQ: LQDA), a promising entity in the biotechnology sector, is capturing investor attention with a compelling potential upside of 74.81%. Specializing in the development of treatments for pulmonary..

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of addressing unmet patient needs, has caught the attention of investors with its impressive 86.72% potential upside. Specializing in the..

Liquidia Corporation (NASDAQ: LQDA) has recently captured the attention of investors, given its substantial upside potential. With a market capitalization of $1.31 billion, this U.S.-based biopharmaceutical company is making waves..